. This 83 broadening of clinical spectra has been important for the demonstration that microvilli 84 are markers of disorders in apical-membrane trafficking and assembly, from bowel to 85 liver 6; 7 . Such variable clinical presentations have also been demonstrated, for other 86 genes responsible for digestive and liver diseases, including ABCB11 8; 9 , TTC37 and 87
SKIV2L
10-12 . Here, we investigated four families presenting with a phenotypic 88 constellation that includes cholestasis, congenital diarrhea, impaired hearing and 89 bone fragility. We were intrigued by the fact that, although several of the presenting 90 features are also encountered in various genetic syndromes, we could not identify 91 examples in the literature in which patients shared all observed pathologies. Given 92 these observations, we hypothesized that the constellation of phenotypes in the 93 individuals in our study likely represent a hitherto unknown clinical entity, which we 94 have named tentatively O2HE (Osteo-Oto-Hepato-enteric) syndrome. To understand 95 the genetic basis of this disorder and to provide an entry point towards both 96 mechanisms and potential therapeutic targets, we studied four patients from three 97 families. By For the rescue experiments, we in vitro transcribed human WT and V423N-encoding 158 mRNA using the SP6 mMessage mMachine kit (Ambion). All injections were done at 159 the 1-4 cell stage and each experiment was performed in triplicate as described 14 . 160
Fluorescent microsphere gavage was performed on 5dpf zebrafish anesthetized in 161 tricaine and mounted in 3% methylcellulose. Injection of Fluoresbrite polychromatic 162 red 2.0 micron microspheres (Polysciences #19508) was gavaged into the zebrafish 163 intestinal lumen as described 15 . Brightfield and gavage images were taken of 5dpf 164 embryos using the Nikon AZ100 microscope with a 2x objective and a 5.0-megapixel 165 DS-Fi1 digital camera as previously described 16 . 166
Serial sections of the zebrafish were obtained by mounting in 3% low-melting point 167 agarose and sections on a vibratome. Standard immunohistochemistry was 168 performed using Phalloidin and 4e8 (both used at 1:1000 dilution). Sections were 169 mounted onto a coverslip using vectashield and imaged on a Nikon Eclipse 90i with a 170 C2-SH camera at 20X. Image analyses and statistics were performed as previously 171 . They are not found in gnomAD 261 database, except for the variant c.2633C>T; p.Ser878Leu which is reported seven 262 times in the heterozygous state (7/277162). 263
Biallelic UNC45A variants were the only sites shared among the two unrelated 264 families with overlapping phenotypic features, thereby bolstering our interest for a 265 likely causal association of UNC45A variants with the disease presentation. 266
We added UNC45A to our candidate gene list and we reanalyzed the exomes of 269 families without molecular diagnosis with phenotypes similar to those exhibited by 270 individuals of families A and B. We discovered two missense mutations in a third 271 unrelated family presenting liver disease and bone frailty. Specifically, in family C, we 272 identified two missense mutations c. 247C>T; p.Arg83Trp and c.983G>T; 273 p.Gly328Val in UNC45A (Figure 1 ). These substitutions are predicted to be 274 damaging; one is only found four times (frequency of 4/276948) in heterozygotes, 275 whereas the second one has never been reported in gnomAD Browser. Given the 276 overlap of clinical features of individual C.II.1 with the clinical spectrum of the other 277 patients described here, these results provided further evidence for a causal 278 association of biallelic UNC45A mutations with this phenotypic presentation. 279 respectively) compared to control cells (Figure 2 C, D) . Furthermore, we did not 289 detect any signal at ~70KDa, which would have corresponded to the truncated 290 protein translated from the UNC45A allele carrying the nonsense mutation p.Gln861*, 291
suggesting that the truncated protein product is unstable. Regarding nonsense 292 variant p.Arg262* in patient A, which maps to exon 11, we likewise did not detect any 293 truncated protein. However, we cannot formally exclude the possibility of a truncated 294 protein since we do not know the lowest detection threshold of our assay; this data 295 suggests there is nonsense mediated mRNA decay (NMD). Of note, in Family C, 296 father C.I.2 who is heterozygous for p.Arg83Trp and the mother C.I.2 who is 297 heterozygous for p.Val423Asp, also had reduced UNC45A levels (45%, and 52% 298 respectively), also indicating that these alleles are associated with reduced protein 299 expression level and lead to the abrogation of protein stability. Together, all these 300 studies suggest a loss of protein abundance/activity paradigm and thus a loss of 301 function disorder. 302
We next asked whether the reduction of UNC45A expression was restricted to 303 lymphoblastoid cells. Using whole cell lysates from patient B.II.3 fibroblasts, we 304 observed an 82% decrease of UNC45A compared to control cells (Figure 2 A, C) . 305
Similar to the previous experiment, we could not detect any signal that might 306 represent the truncated protein, again suggesting NMD. Quantification of the 307 UNC45A mRNA produced in these cells was consistent with this notion; we observed 308 a 40% and 50% decrease of transcripts levels in lymphoblastoid cells of patients 309 B.II.3 and B.II.4 respectively ( Figure S3 . The zebrafish locus is predicted to encode 317 three splice isoforms of unc45a; we focused our studies on the canonical (longest) 318 isoform (ENSDART00000159409.1) which is 64% identical to human UNC45A 319 (ENSG00000140553); the other two isoforms are shorter (230aa and 218 aa versus 320 935 AA for the canonical isoform) ( Figure S8 and S9). We designed a MO against the 321 splice donor site of zebrafish unc45a exon 3. This resulted in the inclusion of intron 3, 322 leading to a premature stop. 323
To assess one of the primary clinical phenotypes of our patients, congenital 324 diarrhea, we tested the effects of suppression of unc45a on both enteric neurons and 325 intestinal motility. We first asked whether this phenotype could be caused by a 326 neurodevelopmental enteric defect. We therefore visualized and counted the neurons 327 along the zebrafish gut by staining with antibodies against HuC/D. In triplicate 328 experiments performed blind to injection cocktail, we could not detect any 329 appreciable difference in the number of enteric neurons in morphants versus 330 controls, suggesting that unc45a suppression does not impact neurodevelopment in 331 the gut (data not shown). Next, we assayed intestinal motility by fluorescent 332 microsphere gavage into the anterior intestine of 5 dpf (days post fertilization) 333 embryos 15; 16 , followed by recording of the rate of intestinal motility of the 334 microspheres as a function of time (imaging at 0, 3, 6, 9 and 24 hrs). At each time 335 point we scored in which intestinal zone (1-4, based on anatomical landmarks) the 336 fluorescent microspheres were located as a measurement of transit through the 337 intestine post-gavage. Performing ordinal logistic regression and repeated measures 338 analysis, we saw that, as time progresses, control larvae are less likely to have 339 microspheres remaining in their intestinal lumen compared to morphants (p<0.0001; 340 OR=0.504), with a majority of morphants having microspheres remaining in their 341 intestine after 24 hours post gavage. These data suggest that suppression of unc45a 342 leads to an intestinal motility defect (Figure 3) . 343
To test this observation further, we turned our attention to a stable genetic 344 model. We obtained the kurzschlusstr12 (kus tr12 ) zebrafish mutant, an aortic arch 345 mutant identified previously in a forward genetic screen caused by a nonsense 346 mutation in unc45a 22 . Although gut motility phenotypes had not been reported 347 previously, such phenotypes are not readily observable; we therefore tested mutants 348 
mutants (data not shown). 361
We next asked if the intestinal motility defect could be linked to structural 362 defects. Observations of control and mutant animals under brightfield showed a lack 363 of folds in the intestine of kus tr12 fish. We therefore performed serial sections and 364 used markers for F-actin (Phalloidin) and intestinal brush borders (4e8) to determine 365 if the defects in intestinal motility we observe in the mutant larvae were the result of 366 structural abnormalities. Analysis of kus tr12 mutant and control serial sections, 367 revealed defects in the structure of zone 2 and 3 of kus tr12 animals (Figure 4 ). 368
Staining with Phalloidin revealed that, as opposed to having the expected epithelial 369 folds lining the lumen, kus tr12 mutant intestinal tubes are devoid of folds in zone 2 and 370 3, corresponding to the anterior intestine. The differences in structure were restricted 371 to, and specific for, zones 2 and 3; there were no structural differences in zone 4 and 372 no brush border defects observed in the kus tr12 embryos, as their enterocytes 373 maintained the expression and localization of 4e8, the absorptive cell marker. 374
Given these phenotypes, we proceeded to test the functionality of the alleles 375 discovered in our cohort. In the Family A, the proband was a compound heterozygote 376 for p.Arg262* and p.Val423Asp, the first mutation being considered to encode a null 377 allele. We therefore modeled p.Val423Asp. To reduce the phenotypic variability that 378 we have sometimes found in morphants, we focused our studies on the of kus tr12 379 homozygous mutants. Specifically, we injected both human wildtype (WT) and 380 V423N encoding mRNA into kus tr12 embryos at the 1-4 cell stage and we assessed 381 their ability to improve the structural phenotypes observed in zone 2 of 5dpf mutant 382 guts. Injection of WT human mRNA was able to ameliorate the observed fold defects. 383
In contrast, human p.Val423Asp mRNA injected kus tr12 larvae were 3.44 times more 384 likely to have no folds in zone 2 than kus tr12 mutants injected with WT mRNA (Figure  385 5, p=0.005; OR=3.441), with modest overall amelioration of the mutant phenotype. 386
Human WT mRNA was unable to rescue zone 3, likely because it forms somewhat 387 later in development at which point the injected mRNA is mostly extinguished, while 388 zone 4 gave no pathology in mutants and therefore served as an indirect quality 389 control for specificity. Taken together, these data suggested that UNC45A plays a 390 role in the development of a functional intestinal system and that the UNC45A variant invertebrates have a single unc-45 gene that is expressed in both muscle and non-407 muscle tissues, whereas vertebrates possess one gene expressed in striated muscle 408 (UNC45B) and another that is expressed more ubiquitously (UNC45A). In fact the 409 phylogeny of UNC-45 homologues showed that this protein family appeared in the 410 Holozoa lineage ( Figure S4 ) and has undergone a duplication event in an ancestor of 411
Vertebrates. This event allowed the specialization of the two resulting paralogues: the 412 muscle Unc45B and ubiquitous Unc45A. This divergence might explain the absence 413 of skeletal muscle pathology in the three families studied here, although additional 414 affected individuals will be required to define the full range of the clinical pathologies 415 associated with UNC45A mutations in humans. 416 UNC45A belongs to the UCS protein family (UNC-45/CRO1/She4p). C. 417 elegans unc-45 was first described after a screening for mutations causing motility 418 disorders (UNC stands for uncoordinated) 23 . . This, coupled to 437 reports that individuals with visceral arteriovenous malformations can be more 438 susceptible to cholestasis 32 makes UNC45A an attractive candidate; however none 439 of the people in our study display vessel malformation. Although this might be due to 440 differences in development and physiology between lower organisms and humans, 441 we favor the hypothesis in which minimal activity of the human alleles (in contrast to 442 null homozygous zebrafish embryos) might protect from this pathology. The 443 discovery of additional mutations at this locus will help clarify these questions. 444
There is a core phenotype: four main signs seen at least in three patients (Figure 1 Mutant embryos were injected with either WT or V423N encoding mRNA and 644 intestinal folds were observed using brightfield microscopy. 
